首页 > 市场调查报告书 > 医疗设备

医学影像诊断分子呈像/呈影剂

造影注射器市场规模、份额和成长分析（按产品、类型、应用、最终用途和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1898706

造影注射器市场规模、份额和成长分析（按产品、类型、应用、最终用途和地区划分）－2026-2033年产业预测

Contrast Media Injectors Market Size, Share, and Growth Analysis, By Product (Injector Systems, Consumables), By Type (Single Head Injectors, Dual-Head Injectors), By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 188 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球造影注射器市场规模将达到 20.6 亿美元，到 2025 年将达到 22.2 亿美元，到 2033 年将达到 41.8 亿美元，预测期（2026-2033 年）的复合年增长率为 8.2%。

全球造影注射器市场受到心血管疾病、癌症和神经系统疾病等慢性病日益普遍的显着影响。精准影像对于有效诊断这些疾病至关重要，而人口老化和对诊断影像检查日益重视进一步推动了市场需求的激增。这促使医疗机构投资于能够提高影像品质并优化造影剂使用的先进注射器。此外，医疗产业正日益转向微创技术，从而推动了对高精度输送系统的需求。诸如从手动系统向自动化系统的转变以及双头注射器的引入等技术进步，正在提高成像精度和工作流程效率，最终推动市场成长，并促进医疗机构采用现代造影注射器。

全球造影注射器市场驱动因素

癌症、心血管疾病和糖尿病等慢性疾病发病率的上升推动了对早期诊断影像解决方案的需求。对这些健康状况快速诊断和监测需求的日益增长，促使医疗机构增加造影输液设备的使用。这一趋势反过来又促进了先进成像技术的应用，并显着推动了市场扩张。此外，人们越来越意识到早期检测在改善患者预后方面的重要性，这进一步刺激了对高效能造影输液设备的需求，从而改善了医疗影像产业的整体环境。

全球造影注射器市场的阻碍因素

医疗设备（例如造影注射器）的监管环境复杂，为产品核可和市场准入带来了巨大挑战。不同地区监管力度的差异会阻碍创新解决方案的及时推出，最终限制产业成长前景，并抑制先进技术的应用。因此，製造商可能难以应对合规的复杂问题，从而扼杀创新，限制新产品的交付以满足不断变化的市场需求，进而影响整个市场的发展和扩张。

全球造影注射器市场趋势

在人工智慧 (AI) 技术的推动下，全球造影注射器市场正经历重大变革。 AI 的整合透过针对个别患者参数优化造影给药方案，提高了诊断影像的准确性、效率和安全性，最终降低了造影肾臟病等疾病的风险。 AI 赋能的注射器具备自动化功能，可简化工作流程并最大限度地减少人为错误，从而减少放射科的资源浪费。此外，预测分析能够实现个人化成像通讯协定，进一步提高诊断结果的准确性。随着 AI 在医学影像领域的应用日益广泛，AI 在造影输液设备中的应用有望推动患者照护的创新和市场成长。这反映了以技术主导的医疗解决方案这一更广泛的趋势。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Bayer AG（Germany）
Medtronic plc（Ireland）
Bracco Imaging SpA（Italy）
Guerbet（France）
Nemoto Kyorindo Co., Ltd.（Japan）
Ulrich GmbH & Co. KG（Germany）
APOLLO RT Co., Ltd.（Japan）
Shenzhen Anke High-tech Co., Ltd.（China）
SinoMD Technology Co., Ltd.（China）
Vivid Medical Imaging Products Co., Ltd.（China）
Mallinckrodt plc（Ireland）
GE Healthcare（USA）
Siemens Healthineers AG（Germany）
Philips（Netherlands）
Terumo Corporation（Japan）
Cook Medical（USA）
Acist Medical Systems, Inc.（USA）

结论与建议

简介目录

Product Code: SQMIG55A2056

Global Contrast Media Injectors Market size was valued at USD 2.06 Billion in 2024 and is poised to grow from USD 2.22 Billion in 2025 to USD 4.18 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

The global contrast media injectors market is significantly influenced by the rising prevalence of chronic diseases such as cardiovascular conditions, cancer, and neurological disorders, which necessitate accurate imaging for effective diagnosis. This surge in demand is further driven by an aging population combined with a growing emphasis on diagnostic imaging procedures, prompting healthcare facilities to invest in advanced injectors that enhance image quality and optimize contrast media usage. Additionally, the industry is experiencing a shift towards minimally invasive techniques, increasing the need for high-precision delivery systems. Technological advancements, including the move from manual to automated systems and the introduction of dual-head injectors, are enhancing imaging accuracy and workflow efficiency, ultimately driving market growth and promoting the adoption of modern contrast media injectors in healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Media Injectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Media Injectors Market Segments Analysis

Global Contrast Media Injectors Market is segmented by Product, Type, Application, End Use and region. Based on Product, the market is segmented into Injector Systems, Consumables and Accessories. Based on Type, the market is segmented into Single Head Injectors, Dual-Head Injectors and Syringeless Injectors. Based on Application, the market is segmented into Radiology, Interventional Cardiology and Interventional Radiology. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contrast Media Injectors Market

The rising incidence of chronic illnesses such as cancer, cardiovascular diseases, and diabetes is driving the demand for early diagnostic imaging solutions. This heightened need for prompt diagnosis and monitoring of these health conditions is prompting healthcare providers to increasingly utilize contrast media injectors. As a result, this trend is significantly contributing to the expansion of the market, as it promotes the adoption of advanced imaging technologies. Consequently, the growing awareness of the importance of early detection in improving patient outcomes is further stimulating the demand for effective contrast media injectors, thereby enhancing the overall landscape of the healthcare imaging sector.

Restraints in the Global Contrast Media Injectors Market

The intricate regulatory landscape governing medical devices, such as contrast media injectors, poses significant challenges that can cause delays in obtaining product approvals and entering the market. Variations in stringent regulations across different regions may obstruct the timely introduction of innovative solutions, ultimately restricting growth prospects and hindering the adoption of advanced technologies within the industry. As a result, manufacturers may find it difficult to navigate the complexities of compliance, which can stifle innovation and limit the availability of new products to meet evolving market demands, thereby impacting overall market development and expansion.

Market Trends of the Global Contrast Media Injectors Market

The Global Contrast Media Injectors market is witnessing a significant transformation driven by advancements in Artificial Intelligence (AI). AI integration enhances precision, efficiency, and safety in diagnostic imaging by optimizing contrast dosing tailored to individual patient parameters, ultimately reducing risks such as contrast-induced nephropathy. The automation capabilities of AI-powered injectors streamline workflows and minimize human errors, which leads to reduced waste in radiological practices. Moreover, predictive analytics facilitate personalized imaging protocols, enhancing diagnostic outcomes. As the adoption of AI in medical imaging escalates, its role in contrast media injectors is poised to revolutionize patient care and propel market growth, reflecting a broader trend towards tech-driven healthcare solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Contrast Media Injectors Market Size by Product & CAGR (2026-2033)

Market Overview
Injector Systems
- CT injector systems
- MRI injector systems
- Cardiovascular/angiography injector systems
Consumables
- Tubing
- Syringe
- Others

Global Contrast Media Injectors Market Size by Type & CAGR (2026-2033)

Market Overview
Single Head Injectors
Dual-Head Injectors
Syringeless Injectors

Global Contrast Media Injectors Market Size by Application & CAGR (2026-2033)

Market Overview
Radiology
Interventional Cardiology
Interventional Radiology

Global Contrast Media Injectors Market Size by End Use & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Centers
Ambulatory Surgery Centers

Global Contrast Media Injectors Market Size & CAGR (2026-2033)

North America (Product, Type, Application, End Use)
- US
- Canada
Europe (Product, Type, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemoto Kyorindo Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ulrich GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
APOLLO RT Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Anke High-tech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SinoMD Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivid Medical Imaging Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acist Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments